Intercept Pharmaceuticals Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:N/A
Industry:Pharma
Founded:2002
Lead Investor(s):N/A

Employee Data

  • Intercept Pharmaceuticals has 686 Employees.
  • Intercept Pharmaceuticals currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
N/A686N/AN/A-N/A
#2
$372.5M1853N/AN/A-N/A
#3
$38.2M190N/AN/A-N/A
#4
N/A36N/AN/A-N/A
#5
$22.1M11024%N/A-N/A
#6
$581.3M2892N/AN/A-N/A
#7
$13.5M67N/AN/A-N/A
#8
$43.4M216N/AN/A-N/A
#9
$15.1M7510%N/A-N/A
#10
$47.4M23615%N/A4.2/5N/A
Missing a competitor? Contribute!?
Submit

New York City-based Intercept Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company focused on developing small molecule drugs for the treatment of chronic liver and metabolic diseases. Since 2002, Intercept researchers have published extensively on the key role of the farnesoid X receptor (FXR) as a regulator of bile and cholesterol metabolism in the liver with preclinical data from numerous studies providing strong rationale for the advancement of FXR agonists as hepatoprotective therapeutics in chronic liver disease. The company intends to lead in the advancement of drug candidates acting on FXR and other bile acid receptors and is developing a pipeline of novel lead compounds for multiple indications.

keywords:N/A

686

Number of Employees

N/A

Revenue (est)

1

Current Jobs

N/A

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$221.6M686N/AN/A-N/A
#2
$140.6M686N/AN/A-N/A
#3
$144.5M688N/AN/A-N/A
#4
$124.9M694N/AN/A-N/A
#5
$157.5M694N/AN/A-N/A